文献速递浆细胞疾病

初始治疗对新诊断多发性骨髓瘤患者健康相关生活质量的影响:Connect® MM登记研究结果

Effect of initial treatment on health-related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect® MM Registry.
PubMed 文献 · Br J Haematol · 2020-10-29

该研究基于美国多中心前瞻性观察性Connect® MM登记研究,比较新诊断多发性骨髓瘤(NDMM)患者接受来那度胺-硼替佐米-地塞米松(RVd,n=445)、硼替佐米-美法仑-泼尼松(VMP,n=77)及Vd或VMP(n=588)的健康相关生活质量(HRQoL)与安全性。结果显示RVd组在FACT-MM、EQ-5D及骨痛量表评分上显著优于Vd/VMP组,严重不良事件率各组相似,提示RVd在真实世界 largely 社区人群中维持了HRQoL。

要点

  • RVd较Vd/VMP显著改善FACT-MM、EQ-5D及骨痛量表HRQoL评分。
  • 各组严重不良事件率相似。
  • 真实世界社区人群中RVd维持了HRQoL。

核心结论

  • 在不立即接受干细胞移植的NDMM患者中,RVd较Vd/VMP显著改善HRQoL且严重不良事件率相似。

研究设计与样本

  • 美国多中心前瞻性观察性队列研究Connect® MM登记,比较RVd(n=445)、VMP(n=77)及Vd或VMP(n=588)的NDMM患者。

主要发现

  • RVd组FACT-MM子量表、EQ-5D总体评分及骨痛量表HRQoL评分较Vd/VMP组显著改善。
  • 各组严重不良事件率相似。

关键数值与推荐

  • RVd组n=445,VMP组n=77,Vd或VMP组n=588。
  • FACT-MM、EQ-5D及骨痛量表评分RVd显著优于Vd/VMP。

临床怎么用

  • 对于不立即移植的NDMM患者,RVd可作为兼顾疗效与HRQoL的初始治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although new multiple myeloma (MM) therapies are effective in alleviating some disease-associated symptoms (e.g. bone pain, fatigue, functional decline), they can result in additional toxicities, further impacting health-related quality of life (HRQoL). Here, we compared HRQoL and safety of lenalidomide-bortezomib-dexamethasone [RVd (n = 445)], bortezomib-melphalan-prednisone [VMP (n = 77)] and Vd or VMP (n = 588) in patients with newly diagnosed MM (NDMM) from the Connect® MM Registry, a large, USA, multicentre, prospective observational cohort study. Functional Assessment of Cancer Therapy-Multiple Myeloma subscale, EuroQol-5D overall score and Bone Pain Inventory HRQoL scores were significantly improved with RVd versus Vd/VMP. Serious adverse event rates were similar in all groups. Treatment with RVd maintained HRQoL in this real-world, largely community-based population of patients with NDMM.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Abonour R, Rifkin RM, Gasparetto C, et al. Effect of initial treatment on health-related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect® MM Registry. Br J Haematol. 2020. PMID: 33118614. doi:10.1111/bjh.17131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。